Search Results 411-420 of 16786 for Fibronolytic

  1. Electrophysiological Biomarkers for Parkinson's Disease - Mayo Clinic

    This study will determine the validity of predictive and surrogate biomarkers for the detection of Parkinson's disease and Parkinson's disease cognitive decline ...

  2. A Study of LNK01002 in Patients With Primary (PMF) or Secondary Myelofibrosis (PV-MF, ET-MF) or Acute Myeloid Leukemia - Mayo Clinic

    The purpose of this study is to evaluate safety and tolerability of multi-kinase inhibitor LNK01002 in patients with primary myelofibrosis (MF), or MF due to ...

  3. Neurology - Clinical trials

    [MUSIC PLAYING]. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first.

  4. Thrombophlebitis - Doctors and departments - Mayo Clinic

    Connect with others like you for support and answers to your questions in the Blood Cancers & Disorders support group on Mayo Clinic Connect, a patient ...

  5. https://www.mayoclinic.org/spanish_patient_consumer_recipe.xml

  6. Fezolinetant (oral route) - Side effects & dosage - Mayo Clinic

    Description. Fezolinetant is used to reduce moderate to severe symptoms of menopause, including feelings of warmth in the face, neck, and chest, ...

  7. Study to Assess Limited Magnetic Resonance Imaging in the Surveillance of Crohn's Disease - Mayo Clinic

    The purpose of this study is to compare a limited magnetic resonance enterography (MREN) to routine MREN in order to determine non-inferiority, missed findings, ...

  8. A Study of Hematopoiesis in Patients with Monoclonal B Cell Lymphocytosis (MBL), B-Chronic Lymphocytic Leukemia (CLL), and Healthy Controls - Mayo Clinic

    About this study. The purpose of this study is to determine the cellular and mechanistic basis of bone marrow hematopoietic dysfunction in untreated ...

  9. A Study to Describe the Tendon Lining Fluid and to Find Out if Ultrasound Can Predict the Amount of Inflammation in Tendon Fluid - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. Publications - Shannon M. Dunlay, M.D., M.S. - Mayo Clinic

    Fibrinolysis vs. primary percutaneous coronary intervention for ST-segment elevation myocardial infarction cardiogenic shock. ESC Heart Fail. 2021 Jun; 8 (3): ...